About ERN LUNG
Expertise
patients
clinicians
ERN-LUNG Academy

The ERN-LUNG Academy is a curriculum for medical staff at any stage of their career, who wishes to get a proof of knowledge on rare respiratory diseases. It consists of Webinars and eCases, but also includes on-site training in ERN-LUNG Centers. We call for applications from participants of EU-member States from September to November each year. Classes start in January. If you wish to apply for next yearโ€™s class, please send a letter of motivation to info@ern-lung.eu

ERN-LUNG Online advance system

The EXpert Advisory BOard (EXABO) is a pan-European internet platform, which has been developed in the context of ERN-LUNG in liaison with the Medical Informatics Group of University Hospital Frankfurt, to answer questions on all aspects of rare respiratory diseases. The platform is primarily aimed at patients and care team members but is openly accessible by anyone who wants to ask a related question.

NETWORK
News

European Joint Action JARDIN kick-off meeting


The conference concludes the three-day launch event of the JARDIN Joint Action on the integration of the European Reference Networks (ERNs) into national health systems and aims to raise awareness of the Joint Action and rare diseases in general in order to reach a wider range of stakeholders.

The Joint Action on Integration of ERNs into National Health Systems (JARDIN) kick-off meeting was held on 6 – 8 March 2024 in Brussels, Belgium. Two days of technical meetings were followed by a session organised by the European Economic and Social Committee on the last day: “Rare Diseases in the EU: Joint Action shaping the future of ERNs”, it highlighted a firm commitment among EU institutions, Member States and the rare disease community to progress towards connecting ERNs and national healthcare systems.
The action is an important part of the ERN initiative, involving all EU Member States, Norway and Ukraine, and aims to help integrate the ERNs into national health systems and ensure their long-term sustainability, for example by developing national patient pathways linked to the ERNs, designing national reference networks modeled on and complementing the ERNs, and developing structures for undiagnosed patients.